Edmonds Mick D, Boyd Kelli L, Moyo Tamara, Mitra Ramkrishna, Duszynski Robert, Arrate Maria Pia, Chen Xi, Zhao Zhongming, Blackwell Timothy S, Andl Thomas, Eischen Christine M
J Clin Invest. 2016 Jan;126(1):349-64. doi: 10.1172/JCI82720. Epub 2015 Dec 14.
MicroRNA (miR) are important regulators of gene expression, and aberrant miR expression has been linked to oncogenesis; however, little is understood about their contribution to lung tumorigenesis. Here, we determined that miR-31 is overexpressed in human lung adenocarcinoma and this overexpression independently correlates with decreased patient survival. We developed a transgenic mouse model that allows for lung-specific expression of miR-31 to test the oncogenic potential of miR-31 in the lung. Using this model, we observed that miR-31 induction results in lung hyperplasia, followed by adenoma formation and later adenocarcinoma development. Moreover, induced expression of miR-31 in mice cooperated with mutant KRAS to accelerate lung tumorigenesis. We determined that miR-31 regulates lung epithelial cell growth and identified 6 negative regulators of RAS/MAPK signaling as direct targets of miR-31. Our study distinguishes miR-31 as a driver of lung tumorigenesis that promotes mutant KRAS-mediated oncogenesis and reveals that miR-31 directly targets and reduces expression of negative regulators of RAS/MAPK signaling.
微小RNA(miR)是基因表达的重要调节因子,miR表达异常与肿瘤发生有关;然而,人们对它们在肺癌发生中的作用了解甚少。在此,我们确定miR-31在人肺腺癌中过表达,且这种过表达与患者生存率降低独立相关。我们构建了一个转基因小鼠模型,该模型允许miR-31在肺中特异性表达,以测试miR-31在肺中的致癌潜力。利用该模型,我们观察到miR-31的诱导导致肺增生,随后形成腺瘤,后期发展为腺癌。此外,在小鼠中诱导miR-31表达与突变型KRAS协同作用可加速肺癌发生。我们确定miR-31调节肺上皮细胞生长,并鉴定出6个RAS/MAPK信号通路的负调节因子作为miR-31的直接靶点。我们的研究将miR-31鉴定为肺癌发生的驱动因子,其促进突变型KRAS介导的肿瘤发生,并揭示miR-31直接靶向并降低RAS/MAPK信号通路负调节因子的表达。